Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75,482,273
-
Total 13F shares
-
6,591,438
-
Share change
-
-737,368
-
Total reported value
-
$4,376,000
-
Price per share
-
$0.66
-
Number of holders
-
35
-
Value change
-
-$753,164
-
Number of buys
-
14
-
Number of sells
-
14
Institutional Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q4 2021
As of 31 Dec 2021 Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) had 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,591,438 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, AIGH Capital Management LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Maven Securities LTD, MORGAN STANLEY, ACT CAPITAL MANAGEMENT, LLC, Worth Venture Partners, LLC, CITADEL ADVISORS LLC, and STATE STREET CORP.
This table shows 35 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.